Psychiatry · San Diego, CA
NPI
1508174970
Since 2010
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3364 Beyer Blvd
San Diego, CA, 92173
Phone (619) 662-4100
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$468K
3,746 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gilberto E Zayas prescribed most often to Medicare patients was Trazodone Hcl, with 490 prescriptions and refills. In total Gilberto E Zayas wrote 3,746 Medicare prescriptions that cost $468K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Trazodone Hcl Generic | 490 | 506 | 84 | $10K |
| Escitalopram Oxalate Generic | 461 | 463 | 73 | $22K |
| Duloxetine Hcl Generic | 332 | 333 | 50 | $29K |
| Sertraline Hcl Generic | 320 | 325 | 48 | $14K |
| Quetiapine Fumarate Generic | 257 | 258 | 39 | $27K |
| Mirtazapine Generic | 222 | 223 | 35 | $7,227 |
| Olanzapine Generic | 139 | 140 | 19 | $25K |
| Fluoxetine Hcl Generic | 129 | 132 | 21 | $7,025 |
| Aripiprazole Generic | 125 | 126 | 21 | $36K |
| Buspirone Hcl Generic | 121 | 124 | 21 | $5,537 |
| Risperidone Generic | 114 | 114 | 15 | $9,834 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 110 | 110 | Under 11 | $7,389 |
| Bupropion Xl Bupropion Hcl | 100 | 104 | 12 | $6,169 |
| Citalopram Hbr Citalopram Hydrobromide | 78 | 83 | 11 | $2,706 |
| Divalproex Sodium Generic | 58 | 58 | Under 11 | $2,358 |
Brand drugs: 156 claims; generic drugs: 3,590 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gilberto E Zayas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.